Accelerating Growth and Enhancing Value for Healthcare
Roth’s Healthcare Team provides financing and strategic advisory services for public and private companies in the life sciences sector. Our clients include both development and commercial stage companies and include companies engaged in the development of novel therapeutic compounds, the application of unique drug discovery and drug delivery technologies, and the development and marketing of biopharmaceuticals, specialty pharmaceuticals, medical devices and diagnostics.
Roth works closely with our clients’ management teams and boards of directors to determine and execute optimal financing strategies. Roth has an extensive track record in executing IPOs, follow-on offerings, PIPEs, registered directs and confidentially marketed public offerings for life sciences companies.
Additionally, Roth also advises our clients on strategic transactions, including mergers, acquisitions, divestitures, reverse mergers, strategic sales, licensing agreements and strategic partnerships, and provides fairness opinions related to such transactions.